Venetoclax and a Pediatric-Inspired Regimen for the Treatment of Newly Diagnosed B Cell Acute Lymphoblastic Leukemia

Clinical trial NCT05157971 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05157971
Sponsor: City of Hope Medical Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

B Acute Lymphoblastic Leukemia Ph-Like Acute Lymphoblastic Leukemia

Start date: 2022-03-17
Primary completion: 2027-04-12
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.